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Abstract
 
Members of the Cbl family of molecular adaptors play key roles in regulating tyrosine kinase-
dependent signaling in a variety of cellular systems. Here we provide evidence that in B cells
Cbl-b functions as a negative regulator of B cell antigen receptor (BCR) signaling during the
normal course of a response. In B cells from Cbl-b–deficient mice cross-linking the BCRs re-
sulted in sustained phosphorylation of Ig
 
 
 
, Syk, and phospholipase C (PLC)-
 
 
 
2, leading to
prolonged Ca
 
2
 
 
 
 mobilization, and increases in extracellular signal–regulated kinase (ERK) and
c-Jun NH
 
2
 
-terminal protein kinase (JNK) phosphorylation and surface expression of the activa-
tion marker, CD69. Image analysis following BCR cross-linking showed sustained polarization
of the BCRs into large signaling-active caps associated with phosphorylated Syk in Cbl-b–defi-
cient B cells in contrast to the BCRs in Cbl-b–expressing B cells that rapidly proceeded to
form small, condensed, signaling inactive caps. Significantly, prolonged phosphorylation of Syk
correlated with reduced ubiquitination of Syk indicating that Cbl-b negatively regulates BCR
signaling by targeting Syk for ubiquitination.
Key words: B cells • antigen receptor • ubiquitination • tyrosine kinase • capping
 
Introduction
 
B lymphocyte responses are initiated by the binding of
multivalent antigens to the B cell antigen receptors
(BCRs),
 
*
 
 an event that triggers signaling cascades resulting
in the transcription of a variety of genes associated with B
cell activation (1). The BCR is composed of antigen bind-
ing chains, the Ig molecules, and a noncovalently associated
signal-transduction complex, Ig
 
 
 
/Ig
 
 
 
, containing in its
cytoplasmic domain immunoreceptor tyrosine-based acti-
vation motifs (ITAMs; reference 2). Cross-linking the
BCR results in the phosphorylation of the ITAMs by the
Src family kinase, Lyn followed by recruitment and activa-
tion of the nonreceptor protein tyrosine kinase, Syk (3–5).
Recruitment of Syk by the phosphorylated BCR is a key
event in the assembly of the BCR signalosome composed
of the adaptor protein BLNK and key downstream signal-
ing components including phospholipase C (PLC)-
 
 
 
2,
Vav, and Bruton’s tyrosine kinase (Btk) (6, 7). Syk defi-
ciencies in mice result in aberrant B cell development (8,
9), and chicken DT40 B cells lacking Syk are unresponsive
to BCR stimulation (10). Given the central role of Syk in
B cell activation, regulation of Syk is likely to be essential
to set the appropriate signaling thresholds for both the initi-
ation and dampening of immune responses. However, the
two known negative regulators of BCR signaling, namely
SHIP and SHP-1, do not appear to target Syk. SHIP is a
lipid phosphatase that influences the levels of PIP-3 (11–
13) and SHP-1, a protein phosphatase, regulates BCR sig-
naling by dephosphorylating Lyn (14).
Recent studies have provided evidence that two mem-
bers of the Cbl family of molecular adaptors, c-Cbl and
Cbl-b, function to regulate signaling in immune cells
downstream of the immune receptors (15, 16). Members of
the Cbl family share several highly conserved features in-
cluding: a tyrosine kinase binding (TKB) domain composed
 
of a four-helix bundle, a Ca
 
2
 
 
 
-binding EF hand motif and
an unusual SH2 domain; a RING finger domain that in-
teracts with ubiquitin conjugating enzymes allowing Cbl
proteins to function as ubiquitin ligases; a proline rich region
involved in SH3-domain interactions; multiple tyrosine res-
idues that when phosphorylated allow interactions with
SH2 domains and luicine zippers (16). Current evidence
indicates that Cbl proteins regulate the activity of protein
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*
 
Abbreviations used in this paper:
 
 BCR, B cell antigen receptor; Btk,
Bruton’s tyrosine kinase; RT, room temperature; TKB, tyrosine kinase
binding; Ub, ubiquitin.T
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tyrosine kinases in part through ubiquitination and degra-
dation of their targets (17–19). Evidence for the role of
c-Cbl and Cbl-b in lymphocyte cell signaling was provided
by the phenotypes of c-Cbl– and Cbl-b–deficient mice, the
most dramatic of which were in T cell compartments (20–
23). These phenotypes provided evidence that c-Cbl and
Cbl-b have distinct functions in T cells. Loss of c-Cbl re-
sulted in severe defects in developing thymocytes but only
mild defects in mature peripheral T cells. Thymocytes from
c-Cbl
 
 
 
/
 
 
 
 mice showed enhanced activation of ZAP-70 af-
ter TCR engagement that was uncoupled from the need
for CD4 costimulation and Lck activation. Consequently,
positive selection of CD4
 
 
 
 thymocytes was enhanced in
c-Cbl
 
 
 
/
 
 
 
 mice (20, 21). In contrast, thymocyte development
was normal in Cbl-b–deficient mice but the peripheral T
cells were hyperreactive. Activation of mature peripheral T
cells from Cbl-b
 
 
 
/
 
 
 
 mice was independent of the engage-
ment of the coreceptor CD28 and consequently Cbl-b
 
 
 
/
 
 
 
mice were highly susceptible to autoimmunity (22, 23).
The effect of Cbl deficiencies in B cells has not been as rig-
orously explored. B cells in c-Cbl
 
 
 
/
 
 
 
 mice appeared in
normal numbers although in some mice an increase in the
number of immature IgM
 
 
 
 IgD
 
–
 
 cells was noted (20), hint-
ing at a developmental defect. B cells from Cbl-b
 
 
 
/
 
 
 
 mice
showed enhanced proliferative responses to BCR cross-
linking and to CD40 stimulation analogous to the T cell
phenotype in these mice (23). Recent evidence indicates
that Cbl-b plays a positive role in signaling in immature
DT40 B cells (24). Here we provide evidence that in ma-
ture splenic B cells Cbl-b is a negative regulator of BCR-
mediated B cell activation in part through its ubiquitination
of Syk.
 
Materials and Methods
 
Mice.
 
Cbl-b
 
 
 
/
 
 
 
 mice on a mixed genetic background be-
tween 129 and C57BL/6 were as described (22). Cbl-b
 
 
 
/
 
 
 
 mice
on a mixed genetic background between 129 and C57BL/6 were
obtained from Taconic. For some analyses, Cbl-b
 
 
 
/
 
 
 
 and Cbl-
b
 
 
 
/
 
 
 
 littermates on the same mixed genetic background were
used.
 
Reagents and Abs.
 
The mouse IgM-specific rat IgG2a mAb
(R6–60.2) used for BCR cross-linking was purchased from BD
Biosciences. F(ab
 
 
 
)
 
2
 
 goat Abs specific for mouse Ig
 
 
 
 or for
IgM 
 
 
 
 G, biotin-conjugated F(ab
 
 
 
)
 
2
 
 goat Abs specific for rat Ig,
HRP-conjugated goat Abs specific for mouse Ig, Rhodamine
Red X (RRX)-conjugated Fab goat Abs specific for mouse Ig
 
 
 
,
PE-conjugated F(ab
 
 
 
)
 
2
 
 donkey Abs specific for rabbit IgG,
FITC-conjugated F(ab
 
 
 
)
 
2
 
 goat Abs specific for mouse IgG, and
Texas-Red–conjugated streptavidin were purchased from Jack-
son ImmunoResearch Laboratories. Latrunculin B, Piceatannol
and PP2 were purchased from Cal Biochem Co. Cytochalasin D
was purchased from Sigma-Aldrich. The following Abs were
purchased: rabbit Abs specific for Syk, Cbl-b, Vav1, BLNK,
Lyn, PLC-
 
 
 
2, ubiquitin, phospho-ERK, ERK or JNK, goat Abs
specific for Btk, and a mouse mAb specific for BLNK (2B11)
from Santa Cruz Biotechnology, Inc.; rabbit Abs specific for
phospho-JNK from Biosource International; rabbit Abs specific
for phospho-Syk (tyrosine 519/520), phospho-Btk (tyrosine
223), phospho-Akt (serine 473), and Akt from Cell Signaling
 
Technology; and the phosphotyrosine specific PY20 mAb from
Transduction Lab. AlexaFluor 488-conjugated to streptavidin,
phalloidin and goat Abs specific for rabbit IgG were purchased
from Molecular Probe. The WASP-GBD-GFP fusion protein
used for the measurement of active CDC42 (25) was a kind gift
of Dr. Michael Rosen (University of Texas Southwestern Medi-
cal Center, Dallas, TX). Rabbit Abs specific for Ig
 
 
 
 was pre-
pared as described (26).
 
B Cell Activation Assay.
 
B cells were purified from red cell
depleted spleen cells by complement-mediated cytotoxicity after
incubation with a Thy-1–specific mAb. The resulting cells were
 
 
 
90% B220
 
 
 
. The cells were incubated with a rat mAb specific
for mouse IgM (1 
 
 
 
g/10
 
6
 
 cells) on ice for 30 min, washed and in-
cubated with F(ab
 
 
 
)
 
2
 
 goat Abs specific for rat IgG Fc
 
 
 
 at 37
 
 
 
C.
Alternatively, cells were incubated with F(ab
 
 
 
)
 
2
 
 goat Abs specific
for mouse IgM at 37
 
 
 
C for the indicated times.
 
Immunoprecipitation, Immunoblotting, and Lyn Kinase Assays.
 
Immunoprecipitation and immunoblotting of cell lysates were as
described previously (27). For immunoprecipitation of Syk, Ig
 
 
 
,
BLNK, phospho-Btk, Vav1, and PLC-
 
 
 
2, 5 
 
 
 
 10
 
7
 
 cells per time
point were lysed in the Tris or MES-buffered saline containing
1% NP-40, sodium orthovanadate, and protease inhibitors. For
immunoprecipitation of Cbl-b and Lyn, 2 
 
 
 
 10
 
7
 
 cells were lysed
in the RIPA buffer containing 1% NP-40, 0.5% sodium deoxy-
cholate, 0.1% SDS, sodium orthovanadate, and protease inhibi-
tors. Lyn kinase activity was measured in Lyn immunoprecipitates
by the transfer 
 
 
 
P
 
32
 
 into a peptide substrate using the SignaTECT
protein tyrosine kinase assay system according to the manufac-
turer’s protocol (Promega). Briefly, the Lyn immunoprecipitates
were incubated with kinase buffer including biotin-conjugated
Src kinase–specific peptide substrates and 
 
 
 
P
 
32
 
-ATP for 20 min at
25
 
 
 
C. The reaction was stopped and the reaction mixtures dotted
on to membranes to which streptavidin was coupled. The mem-
branes were washed and counted using a 
 
 
 
-scintillation counter.
For immunoblotting of unfractionated lysates, cells were lysed in
the RIPA buffer and 20 
 
 
 
g of protein per time point was ana-
lyzed. The immunoblot bands were quantified by densitometry
and expressed as a ratio of phosphotyrosine containing protein to
total protein.
 
Measurement of Intracellular Ca
 
2
 
 
 
 Mobilization.
 
For detection
of cytosolic Ca
 
2
 
 
 
, 10
 
7
 
 splenocytes were incubated with 0.75 
 
 
 
M
Indo-1 acetoxy-methyl ester (Indo-1; Molecular Probe) in 1%
HBSS-FBS containing 0.01% F-127 (Molecular Probe) for 45
min at 30
 
 
 
C. Cells were subsequently stained with PE-conjugated
B220 specific mAb to detect B220
 
 
 
 cells in flow cytometry. The
primary IgM-specific Ab was added followed by the secondary
Ab and cytosolic Ca
 
2
 
 
 
 fluxes were recorded in real time using a
FACS vantage (Becton Dickinson) and analyzed by the FlowJo
software program (True Star, Inc.).
 
Determination of F-actin Polymerization and CDC42 Activation.
 
F-actin was detected by phalloidin staining quantified by flow
cytometry. GTP-bound CDC42 was detected using WASP-
GBD-GFP fusion protein as described previously (25). Cells
were fixed, permeabilized with 0.05% saponin and stained with
rabbit Abs specific for GFP followed by FITC-labeled goat Abs
specific for rabbit Ig and analyzed by flow cytometry (FAC-
Scan™; Becton Dickinson).
 
Detection of Phospho-Btk.
 
The level of intracellular phospho-
Btk was determined by flow cytometry using phospho-Btk–spe-
cific antibodies. Splenic B cells (10
 
7
 
 cells/ml) were incubated in
HBSS for 1 h at 37
 
 
 
C and stimulated by adding 20 
 
 
 
g/ml F(ab
 
 
 
)
 
2
 
goat Abs specific for mouse Ig
 
 
 
 for the indicated time periods.
After washing twice with PBS containing 0.2% sodium azide,T
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cells were fixed, permeabilized, blocked with 10% normal mouse
and donkey sera on ice, stained with rabbit Abs specific for phos-
pho-Btk (Y223)-or as a control nonspecific rabbit Ig detected us-
ing PE-conjugated F(ab
 
 
 
)
 
2
 
 donkey Abs specific for rabbit IgG.
After acquisition by FACScan™ (Becton Dickinson), the data
were analyzed by the FlowJo software program. The percentage
of the phospho-Btk–positive cells relative to control Ab stained
cells was calculated after gating on live cells by the forward- and
side-scatter.
 
Immunofluorescence Microscopy.
 
To quantify the number of
cells showing patch, Cap I or Cap II BCR structures, purified
splenic B cells were treated with a rat mAb specific for mouse
IgM at 4
 
 
 
C for 30 min then transferred to poly-
 
l
 
-lysine treated
coverslips at 4
 
 
 
C. Biotin-conjugated goat antibodies specific for
rat IgG were added to further cross-link the BCR and the cells
warmed to 37
 
 
 
C for the times indicated. At the end of each time
point the cells were fixed with 3.7% paraformaldehyde,
quenched with 50 
 
 
 
M NH
 
4
 
Cl, blocked with PBS containing 1%
BSA (PBS-BSA) for 30 min at room temperature (RT) and
stained with AlexaFluor 488-conjugated streptavidin in the dark
for 30 min at RT. The coverslips were mounted in Prolong An-
tifade (Molecular Probe) and examined by fluorescence micros-
copy (Olympus IX70 microscope, 100 W mercury lamp, a
cooled CCD camera, 60 
 
 
 
 1.4 oil objectives). The cells having a
BCR patch, Cap I, or Cap II morphology were counted at each
time point.
To image Ig
 
 
 
 and phosphotyrosine in patch-, Cap I–, Cap II–
positive cells, splenic B cells were incubated with a rat mAb spe-
cific for IgM at 4
 
 
 
C, washed, allowed to settle on coverslips on
ice, and further cross-linked with biotin-conjugated goat Abs
specific for rat IgG for 5 min for patch and Cap I and for 30 min
for Cap II at 37
 
 
 
C. Fixed cells were incubated with Texas Red–
conjugated Streptavidin washed, permeabilized with 0.05% sapo-
nin in PBS-BSA, blocked with 50 
 
 
 
g/ml of purified normal goat
IgG for 30 min at RT, and incubated with PY20 mAb specific
for phosphotyrosine for 1 h at RT. The secondary FITC-conju-
gated goat F(ab
 
 
 
)
 
2
 
 anti–mouse, Fc
 
 
 
-specific Ab, was added for 30
min at RT. For imaging of IgM and phospho-Syk, and IgM and
Syk, splenic B cells were incubated with Fab goat Abs specific for
mouse Ig
 
 
 
 conjugated with Rhodamine Red-X (RRX) for 15
min at RT, washed, and allowed to settle onto an poly-
 
l
 
-lysine
coated 8-well glass-bottom chamber slide (Labtek/Nunc) on ice
for 30 min. Cells were stimulated with 50 
 
 
 
g/ml of F(ab
 
 
 
)
 
2
 
 goat
Abs specific for mouse IgM 
 
 
 
 G at 37
 
 
 
C for the indicated times
and fixed. After quenching, cells were permeabilized with 0.05%
saponin in PBS-Gelatin (PBS containing 1% fish skin gelatin),
blocked with 10% normal mouse sera and 50 
 
 
 
g/ml of purified
normal goat IgG for 30 min at RT. Cells were stained with rabbit
Abs specific for Syk or phospho-Syk (Y519/520) detected using
goat Abs specific for rabbit IgG conjugated with AlexaFluor 488.
For two-color confocal and differential interference contrast
(DIC) images, a confocal laser scanning microscope (Zeiss Axio-
vert 200M LSM 510 META; Carl Zeiss Microimaging, Inc.) fit-
ted with a 1.4 oil planapochromat 
 
 
 
63 objective was used. Im-
ages were acquired with configuration of Ex488/Em 505–530BP
for AlexaFluor 488 or FITC and Ex543/Em 560LP for Texas
Red Dye or RRX and under the scan control of fixed pixel den-
sity at 512 
 
 
 
 512 pixels, 8 bit (phosphotyrosine) or 12 bit (phos-
pho-Syk and Syk) pixel depths, linear contrast of grayscale, 7.8
ms scan time, and pinhole size of 45 
 
 m (phosphotyrosine and
IgM) or 66  m (phospho-Syk/Syk and IgM). No significant sig-
nal saturation was noted in any of the images used for analysis. To
quantify the colocalization between IgM and phosphotyrosine,
phospho-Syk or Syk, the LSM5 imaging examiner software pro-
gram was used. To compare the intensity of phospho-Syk colo-
calized with IgM between Cbl-b /  and Cbl-b /  splenic B
cells, the images from five randomly chosen fields each contain-
ing at least 400 cells were acquired as grayscale with linear con-
trast. The mean fluorescence intensity (MFI) of phospho-Syk
colocalized with IgM was calculated based on the colocalization
scatter diagrams by multiplying both IgM and phospho-Syk posi-
tive, matched pixel numbers by the MFI of the matched pixels
and then dividing by the number of cells in a chosen field.
Results
Prolonged Phosphorylation of Ig  and Syk after BCR Cross-
linking in Cbl-b /  B Cells. B cells from Cbl-b–deficient
mice were shown previously to hyper-proliferate in re-
sponse to BCR cross-linking suggesting a role for Cbl-b in
the negative regulation of B cell signaling. One of the earli-
est events in BCR signaling is the tyrosine phosphorylation
of the Ig /Ig  complex by the Src-family kinase Lyn (3).
The phosphorylation of Ig  results in the recruitment of
Syk to Ig  via its SH2 domains and the subsequent phos-
phorylation of Syk (4). The subsequent Syk-mediated
phosphorylation of the B cell adaptor protein BLNK links
the BCR to both PLC- 2 and Btk. To investigate the mo-
lecular mechanisms underlying the hyper-responsiveness of
B cells from Cbl-b /  mice, we began by monitoring the
tyrosine phosphorylation of Cbl-b, Lyn, Ig , and Syk after
BCR cross-linking. B cells from Cbl-b /  and Cbl-b / 
mice were incubated with F(ab )2 IgM-specific Abs to
cross-link the BCR for increasing lengths of time at 37 C
and at the end of each time point the phosphorylation state
of Cbl-b, Lyn, Ig , and Syk was determined by immuno-
precipitation of each protein followed by immunoblots
probing with a phosphotyrosine-specific mAb.
In B cells from Cbl-b /  mice, Cbl-b was not detectably
phosphorylated in resting cells, but became phosphorylated
immediately upon cross-linking (Fig. 1 A). Phosphorylation
of Cbl-b increased after 2 min at 37 C then decreased ap-
proaching unactivated levels by 30 min. In control experi-
ments, Cbl-b was not detected in Cbl-b /  B cells (Fig. 1
A). The phosphorylation of Cbl-b following BCR cross-
linking suggests that it plays a direct role in BCR signaling.
In both Cbl-b /  and Cbl-b /  B cells Lyn showed a
high level of constitutive phosphorylation that increased
slightly upon BCR cross-linking and remained phosphory-
lated for the 30-min time course (Fig. 1 B). The level of
Lyn phosphorylation, assessed by the ratio of the densities
of the Lyn bands in immunoblots to the densities of the
phospho-Lyn bands, was slightly higher ( 10%) in B cells
from Cbl-b /  as compared with Cbl-b /  mice. Other-
wise, the absence of Cbl-b did not appear to have a signifi-
cant effect on Lyn phosphorylation. Direct measurements
of the kinase activity of Lyn in vitro showed no significant
differences in Lyn activity in Lyn immunoprecipitates from
cell lysates prepared from B cells from Cbl-b /  as com-
pared with Cbl-b /  mice after BCR cross-linking (Fig. 1
C). Resting Cbl-b /  B cells may have a slightly higherT
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level of Lyn activity as compared with Cbl-b /  B cells re-
flecting the slightly higher level of Lyn phosphorylation in
Cbl-b /  B cells.
Cross-linking the BCR resulted in the tyrosine phos-
phorylation of Ig  in B cells from both Cbl-b /  and Cbl-
b /  mice detected immediately upon cross-linking (Fig. 2
A, left panel). Quantitation of the bands corresponding to
Ig  and phosphorylated Ig  showed slightly greater phos-
phorylation of Ig  in Cbl-b /  B cells (a ratio of tyrosine-
phosphorylated Ig  to total Ig  of 1) as compared with
Cbl-b /  B cells (a ratio of 0.75). Significantly, the phos-
phorylation of Ig  was prolonged in B cells lacking Cbl-b
(Fig. 2 A). In Cbl-b /  B cells Ig  phosphorylation re-
turned to nearly unstimulated levels 10 min following
BCR cross-linking (a ratio of 0.2). In contrast, a large por-
tion of Ig  in Cbl-b /  B cells remained phosphorylated at
10 min (a ratio of 0.7).
The phosphorylation of Syk was similarly prolonged in
Cbl-b /  B cells (Fig. 2 B). BCR cross-linking resulted in
slightly higher phosphorylation of Syk immediately follow-
ing cross-linking in Cbl-b /  B cells (a ratio of 1.1) as
compared with Cbl-b /  B cells (a ratio of 0.9). Syk re-
mained phosphorylated for a longer period of time in Cbl-
b /  B cells compared with Cbl-b /  B cells (a ratio of 0.8
versus 0.4 measured at 10 min). The phosphorylation of
Syk on Y519/520 within its activation loop is essential for
Syk’s activity (17, 28). Immunoblots of Syk immunopre-
cipitates probed with polyclonal Abs specific for Syk phos-
phorylated on Y519/520 showed approximately twofold
more Y519/520 phospho-Syk in Cbl-b /  as compared
with Cbl-b /  B cells 2 min after BCR cross-linking (Fig.
2 C). Significantly, phosphorylated Syk remained associated
with Ig  for longer periods of time in Cbl-b /  B cells as
compared with Cbl-b /  B cells (Fig. 2 A, right panel).
Syk was immunoprecipitated with Ig  in resting cells,
however, the Ig -associated Syk was not phosphorylated.
Immediately upon BCR cross-linking the Syk associated
with Ig  was phosphorylated. The amount of phospho-Syk
associated with Ig  showed a significant decrease in Cbl-
b /  B cells 10 min after BCR cross-linking relative to that
in Cbl-b /  B cells (a ratio of 0.2 versus 0.9).
The association of phospho-Syk with the BCR was im-
aged in B cells following BCR cross-linking. B cells were
incubated with RRX-conjugated Fab goat Abs specific for
Ig , washed and allowed to settle on coverslips before
cross-linking the BCR by addition of goat Abs specific for
mouse IgM. Cells were incubated at 37 C for 0 to 30 min,
fixed, permeabilized, and stained for phospho-Syk using
phospho-Syk (Y519/520)-specific rabbit Abs detected us-
ing AlexaFluor 488-conjugated goat Abs specific for rabbit
IgG. The cells were imaged by laser scanning confocal mi-
croscopy and representative merged images acquired 2 min
after BCR cross-linking are shown (Fig. 2 D, top). In un-
treated resting cells no phospho-Syk was detected in either
Cbl-b /  or Cbl-b /  B cells. 2 min after BCR cross-link-
ing the images appeared to show a larger number of cells
with cap structures in which the BCR and phospho-Syk
were colocalized in Cbl-b /  as compared with Cbl-b / 
B cells. To quantify the amount of BCR and phospho-Syk
that were colocalized, the images were analyzed pixel by
pixel and the FI of the IgM RRX and phospho-Syk
(Y519/520) AlexaFluor 488 within each pixel plotted in a
histogram (Fig. 2 D, bottom). Pixels that lie along the diag-
onal contain equal amounts of colocalized IgM and phos-
pho-Syk (Y519/520). For those above the diagonal the in-
tensity of the phospho-Syk (Y519/520) is less than that of
the BCR and for pixels below the diagonal the phospho-
Syk (Y519/520) intensity is greater than that of the BCR.
The histograms indicate less colocalization of phospho-Syk
with the BCR at the 2 min time point in Cbl-b /  B cells
as compared with Cbl-b /  B cells (Fig. 2 D, bottom). For
each time point, the MFI of the phospho-Syk (Y519/520)
colocalized with the BCR was quantified (Fig. 2 E). The
degree of colocalization of phospho-Syk and the BCR was
similar immediately after the addition of the BCR cross-
Figure 1. Cbl-b is phosphorylated following BCR cross-linking but
does not affect Lyn activity. Purified splenic B cells from Cbl-b /  and
Cbl-b /  mice were incubated with F(ab )2 goat Abs specific for mouse
Ig  at 37 C for the indicated times. The cells were washed, lysed, and the
lysate subjected to immunoprecipitation using Abs specific for Cbl-b (A)
or Lyn (B) and the immunoprecipitate analyzed by SDS-PAGE and im-
munoblotting probing for phosphotyrosines using the phosphotyrosine-
specific mAb PY20, stripped, and reprobed for either Cbl-b (A) or Lyn
(B). The results shown are representative of three independent experi-
ments. The Lyn kinase activity was measured in Lyn immunoprecipitates
of lysates of B cells from Cbl-b /  and Cbl-b /  mice at various times af-
ter cross-linking the BCR (C). The results from three experiments were
averaged and the results expressed relative to the Lyn activity in resting
Cbl-b /  B cells.T
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linking Abs (the 0 min time point) in Cbl-b /  and Cbl-
b /  B cells. 2 min after BCR cross-linking the amount of
phospho-Syk (Y519/520) associated with the BCR in-
creased significantly in Cbl-b /  B cells and then decreased
with time. In contrast, in Cbl-b /  B cells the amount of
phospho-Syk (Y519/520) colocalized with the BCR had
already decreased 2 min after BCR cross-linking. These re-
sults taken together with those above indicate that Syk is a
target of Cbl-b activity after BCR cross-linking resulting in
the rapid turnover of active phospho-Syk (Y519/520) asso-
ciated with Ig .
Increased Syk Ubiquitination in Cbl-b /  B Cells. The
members of the Cbl family have been shown to function as
E3 ubiquitin ligases and to target protein tyrosine kinase
substrates for degradation (17). To investigate the possibil-
ity that Cbl-b influences Syk through ubiquitination, Syk
was immunoprecipitated from lysates of Cbl-b /  and Cbl-
b /  B cells treated to cross-link the BCR for varying
lengths of time and the immunoprecipitates analyzed by
immunoblot probing for ubiquitin, Syk and phosphoty-
rosine. The results from the 2-min time point are shown
(Fig. 3). In resting B from both Cbl-b /  and Cbl-b /  a
portion of Syk is tyrosine phosphorylated. A high molecu-
lar weight band reacting with both Syk- and phosphoty-
rosine-specific antibodies appears to be ubiquitinated and
may represent a product of constitutive turnover. Cross-
linking the BCR resulted in increased tyrosine phosphory-
lation of Syk and heterogeneous and poly-ubiquitination of
Syk in Cbl-b /  B cells. In contrast, although Syk is phos-
phorylated the ubiquitination of Syk was significantly less
Figure 2. Phosphorylation of Ig  and Syk and associa-
tion of phospho-Syk with the BCR is prolonged in acti-
vated Cbl-b /  B cells. (A) Purified splenic B cells from
Cbl-b /  and Cbl-b /  mice were treated to cross-link
the BCR by incubation with a rat mAb specific for mouse
IgM on ice for 30 min followed by incubation with F(ab )2
goat Abs specific for rat IgG at 37 C for the times indi-
cated. At the end of each time point the cells were lysed, and the lysates sub-
jected to immunoprecipitation using Ig -specific Abs. The Ig  immunopre-
cipitates were analyzed by SDS-PAGE and immunoblotting probing for
phosphotyrosine-containing proteins, stripped, and reprobed for either Ig 
(left panel) or Syk (right panel) using specific Abs. (B) B cells from Cbl-b / 
and Cbl-b /  mice were treated as in panel A to cross-link the BCR and at
the end of each time point cells were lysed and Syk immunoprecipated from
the lysates. The Syk immunoprecipitates were analyzed by SDS-PAGE and
immunoblotting probing first with a phosphotyrosine-specific mAb, stripped,
and reprobed for Syk. (C) Cbl-b /  and Cbl-b /  B cells were treated in
panel A to cross-link the BCR and incubated for 2 min at 37 C and lysed.
Syk was immunoprecipitated from the lysates and the immunoprecipitates an-
alyzed by SDS-PAGE and immunoblotting. The blots were first probed using
phospho-Syk (Y519/520) specific Abs, stripped and reprobed with Syk-spe-
cific Abs. (D) B cells from Cbl-b /  and Cbl-b /  mice were imaged by laser
scanning confocal microscopy to determine the colocalization of the BCR
and phospho-Syk (Y519/520) as detailed in Materials and Methods. Briefly, B
cells were incubated with RRX-conjugated Fab goat Abs specific for mouse
Ig , washed, allowed to settle onto coverslips, and activated by the addition
of goat Abs specific for mouse IgM for 0 to 30 min at 37 C. The cells were
fixed, permeabilized, and stained with rabbit Abs specific for phospho-Syk
(Y519/520) detected using AlexaFluor 488-conjugated goat Abs specific for
rabbit Ig. The cells were imaged by confocal laser scanning microscopy using
a Zeiss Axiovert 200M LSM 510 META. A representative field is shown 2
min after BCR cross-linking (top) and the RRX and AlexaFluor 488 intensi-
ties of each pixel are plotted (bottom). (E) The average MFI of the AlexaFluor
488 colocalized with RRX for five fields of cells at each time point is given.T
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in Cbl-b /  B cells and appeared to involve primarily the
most highly ubiquitinated forms of Syk detected in resting
cells. In controls, there was no detectable ubiquitination of
Ig  in Cbl-b /  or Cbl-b /  B cells at any time following
BCR cross-linking (unpublished data). However, it is pos-
sible that in addition to Syk proteins coimmunoprecipitated
with Syk are ubiquitinated. Ubiquitination of Syk was
maximal at two min following BCR cross-linking (unpub-
lished data) at a time at which the levels of phospho-Syk
(Y519/520) began decreasing in Cbl-b /  B cells (Fig. 2,
D and E) suggesting that Cbl-b targets phospho-Syk for
ubiquitination resulting in its subsequent degradation.
Prolonged Phosphorylation of BLNK, Btk and PLC- 2 and
Ca2  Fluxes in Cbl-b /  B Cells. A key downstream ef-
fector of BCR signaling is PLC- 2 that cleaves PIP2 (4, 5)
releasing IP3 and DAG resulting in release of intracellular
Ca2  stores. PLC -2 is phosphorylated by Syk and Btk
which are activated by phosphorylation by Lyn (6). BLNK
plays a key role in Ca2  signaling by functioning as a scaf-
fold for the assembly of complexes of PLC- 2 and Btk
after Syk-mediated phosphorylation. Recent evidence in-
dicates that normal Ca2  signaling requires BLNK-depen-
dent PLC- 2–BLNK interactions and BLNK-independent
Btk activation as well as the assembly of BLNK-PLC- 2–
Btk complexes (29). To determine if a Cbl-b deficiency
influenced these events the levels of phosphorylation of
BLNK, Btk, and PLC- 2 and Ca2  fluxes were measured
in Cbl-b /  or Cbl-b /  and Cbl-b /  B cells after BCR
cross-linking.
In Cbl-b /  B cells the phosphorylation of BLNK was
prolonged as compared with Cbl-b /  B cells (Fig. 4 A). In
Cbl-b /  B cells maximal BLNK phosphorylation oc-
curred immediately following BCR cross-linking and de-
creased rapidly thereafter. In contrast, BLNK remained sig-
nificantly phosphorylated 10 min after BCR cross-linking
in Cbl-b /  B cells. Thus, Cbl-b influenced the duration
of the phosphorylation of BLNK.
Cbl-b also affects the phosphorylation state of Btk (Fig. 4
B). B cells from Cbl-b /  and Cbl-b /  mice were treated
with IgM-specific antibodies to cross-link the BCR and at
various times afterward the cells were permeabilized,
stained with Abs specific for phospho-Btk (Y223) and ana-
lyzed by flow cytometry. The levels of phosphorylated Btk
increased immediately after BCR cross-linking in B cells
from both Cbl-b /  and Cbl-b /  mice. However, Btk
phosphorylation reached higher levels in Cbl-b /  B cells
as compared with Cbl-b /  B cells 2–10 min following
BCR cross-linking.
To further characterize the phospho-Btk (Y223) in
terms of its association with PLC- 2 and Syk, cells were
lysed at various times after BCR cross-linking and the ly-
sates subjected to immunoprecipitation using phospho-Btk
(Y223)-specific Abs. The immunoprecipitates were immu-
noblotted probing for phosphotyrosine, stripped and re-
probed for Btk, PLC- 2, and Syk using specific antibodies
(Fig. 4 C). The phospho-Btk (Y223) immunoprecipitates
contained Btk, only weakly detected in immunoblot,
and phospho-PLC- 2 and phospho-Syk. Significantly, the
phospho-Btk/phospho-PLC- 2/phospho-Syk complex re-
mains assembled for longer periods of time in Cbl-b /  as
compared with Cbl-b /  B cells (Fig. 4 C).
The direct effect of Cbl-b on PLC- 2 phosphorylation
was measured. In resting B cells from both Cbl-b /  and
Cbl-b /  mice there was no significant phosphorylation of
PLC- 2 (Fig. 5, top). Upon BCR cross-linking PLC- 2
was phosphorylated in Cbl-b /  mice and by 15 min fol-
lowing BCR cross-linking the amount of phosphorylated
PLC- 2 had decreased significantly. In Cbl-b /  B cells,
PLC- 2 was phosphorylated upon BCR cross-linking but
in contrast to the PLC- 2 in Cbl-b /  B cells, PLC- 2
was strongly phosphorylated at 15 min and a decrease in
phosphorylation was not detected until 30 min after BCR
cross-linking. Consistent with this observation Ca2  fluxes
after BCR cross-linking in Cbl-b /  B cells were more
persistent as compared with those in Cbl-b /  B cells (Fig.
5, bottom). Taken together these results indicate that in the
absence of Cbl-b, complexes containing phosphorylated
Syk, BLNK, Btk and PLC- 2 persist leading to prolonged
Ca2  fluxes.
The Association of Vav-1 with Syk Is Prolonged in Cbl-b / 
B Cells. Vav, a guanine-nucleotide exchange factor or
GEF for the Rho/Rac family of GTPases, plays a central
role in integrating signaling from the BCR. Vav activity is
regulated, in part, by phosphorylation by Syk (30). Evi-
dence for a role for Cbl-b in regulating the function of Vav
in lymphocytes was provided by the observation that the
phosphorylation of Vav-1 was increased in Cbl-b /  T
cells as compared with Cbl-b /  T cells (22, 23). To inves-
tigate the effect of a Cbl-b deficiency on Vav-1 phosphory-
lation, Vav was immunoprecipitated from Cbl-b /  and
Figure 3. The activation-induced ubiquitination of Syk is reduced in
Cbl-b /  B cells. Splenic B cells from Cbl-b /  and Cbl-b /  mice were
treated as in Fig 2, A–C, to cross-link the BCR and warmed to 37 C for
increasing lengths of time. The cells were lysed, and Syk was immuno-
precipitated and analyzed by SDS-PAGE and immunoblotting. Duplicate
immunoblots were probed for either ubiquitin (anti-Ub) or phosphoty-
rosine (Anti-PTyr). The phosphotyrosine blot was stripped and reprobed
for Syk (anti-Syk). The results for the 2-min time point are shown at
which point ubiquitination of Syk was maximal. The result shown is rep-
resentative of three independent experiments.T
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Cbl-b /  B cells before and at various times after BCR
cross-linking and the immunoprecipitates analyzed by im-
munoblot probing for phosphotyrosine. In resting B cells
from both Cbl-b /  and Cbl-b /  mice low levels of
phosphorylated Vav-1 were detected (Fig. 6 A). BCR
cross-linking resulted in the rapid phosphorylation of Vav-1
in both Cbl-b /  and Cbl-b /  B cells which persisted
for the 30-min course of the experiment. Densitometry
analyses of the intensities of the bands in the Vav and phos-
photyrosine immunoblots in Fig. 6 A indicated a small in-
crease in the level of phosphorylation of Vav at the 2 and 5
min time point in Cbl-b /  versus Cbl-b /  B cells, how-
ever, this increase was not completely reproducible. Signif-
icantly, the association of Vav with Syk was prolonged in
Cbl-b /  B cells as compared with Cbl-b /  B cells. Prob-
ing immunoblots of Vav-1 immunoprecipitates for Syk
showed larger amounts of Syk associated with Vav at early
time points after BCR cross-linking that persisted for
longer in Cbl-b /  as compared with Cbl-b /  B cells
(Fig. 6 A). Probing the immunoblot for phosphotyrosine-
containing proteins indicated that the Syk associated with
Vav was phosphorylated (Fig. 6 A). In addition to phos-
phorylated Syk, a phosphoprotein migrating at 77 kD was
also more strongly associated with Vav-1 in Cbl-b /  as
compared with Cbl-b /  B cells. The identity of this pro-
tein is not known, however, given that Btk is phosphory-
lated upon BCR cross-linking (Fig. 4) and associates with
phospho-Syk (Fig. 4) and based on its MW, Btk is a good
candidate for this 77 kD phosphoprotein.
Syk has also been shown to play an important role in acti-
vating PI3K through phosphorylation (31). Little differences
were detected in Cbl-b /  versus Cbl-B /  B cells in the
phosphorylation of PI3K (unpublished data) or Akt (Fig. 6
B), a downstream effector of PI3K. Thus, Cbl-b deficiencies
do not appear to significantly affect the phosphorylation of
proteins in the PI3-K pathway downstream of Syk.
Prolonged Phosphorylation of ERK and JNK in Cbl-b /  B
Cells. The MAP kinases, ERK and JNK, that regulate
nuclear transcription events are also major downstream tar-
gets of BCR signaling cascades leading to B cell activation
(4). To determine if these pathways were influenced by
Cbl-b, the level of tyrosine phosphorylation of ERK 1 and
2 and JNK 1 and 2 were monitored at various times after
BCR cross-linking. As compared with Cbl-b /  B cells,
ERK was more strongly phosphorylated throughout a 20
min time course in Cbl-b /  B cells (Fig. 7 A). Similarly,
both forms of JNK were more strongly phosphorylated in
Cbl-b /  as compared to Cbl-b  /  B cells (Fig. 7 A).
Thus, the signaling pathways involving ERK and JNK ap-
pear to be regulated by Cbl-b. Consistent with the in-
creased activation of ERK in Cbl-b /  B cells, Cbl-b /  B
cells showed greater expression of the early activation
Figure 4. The phosphoryla-
tion of BLNK and Btk is influ-
enced by Cbl-b. (A) B cells from
Cbl-b /  and Cbl-b /  mice
were treated as in Fig. 1 to cross-
link the BCR at 37 C for the
times indicated. The cells were
lysed and BLNK was immuno-
precipitated from the lysates. The
BLNK immunoprecipitates were
analyzed by SDS-PAGE and im-
munoblotting probing with a
phosphotyrosine-specific mAb or
with a BLNK-specific mAb. (B) B
cells from Cbl-b /  and Cbl-b / 
mice were treated as in Fig. 1 to
cross-link to BCR at 37 C for 0
to 30 min, fixed, permeabilized,
and stained with rabbit phospho-
Btk (Y223)-specific Abs detected
using PE-conjugated Abs specific
for rabbit Ig. The cells were ana-
lyzed by flow cytometry and the
percent phospho-Btk positive cells
relative to the negative control is
given for each time point. (C) B
cells from Cbl-b /  and Cbl-b / 
mice were treated as in B to cross-
link the BCR, lysed and the ly-
sates immunoprecipitated using
the phospho-Btk (Y223)-specific
Abs and the immunoprecipitates
analyzed by immunoblot probing
first using a phosphotyrosine-spe-
cific mAb, stripped, and re-
probed using antibodies specific
for PLC- 2, Btk, or Syk.T
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1518 Cbl-b Negatively Regulates BCR Signaling
marker CD69 that is partially dependent on ERK activa-
tion (32). Maximal expression of CD69 was induced by
treating the cells with 10  g/ml IgM-specific antibody to
cross-link the BCR in both Cbl-b /  and Cbl-b /  B cells
but maximal CD69 expression was over twofold greater in
Cbl-b /  B cells (Fig. 7 B).
The Formation of Signaling Active BCR Cap Structures Is
Prolonged in Cbl-b /  B Cells. After cross-linking, the
BCR clusters to form patches that subsequently move to
one pole of the B cell to form a cap that is ultimately con-
densed and internalized (33). Recent evidence suggests that
the cap is a region of active signaling and that Syk promotes
and stabilizes cap formation in B cells (34). As described
above (Fig. 2, D and E) after BCR cross-linking the BCR
remained colocalized with phospho-Syk for a longer period
of time in Cbl-b /  as compared with Cbl-b /  B cells.
The cross-linking-induced capping of the BCR and colo-
calization of the BCR with tyrosine phosphorylated pro-
teins, specifically with Syk and phospho-Syk, was further
characterized. B cells were incubated at 4 C with IgM-spe-
cific rat mAbs followed by biotin-conjugated goat Abs spe-
cific for rat Ig, washed, and warmed to 37 C for increasing
lengths of time. The cells were fixed, and incubated with
Texas Red–conjugated streptavidin to detect the BCR. To
detect phosphotyrosine-containing proteins, the cells were
permeabilized and incubated with the phosphotyrosine-
specific mAb, PY20, detected using FITC-conjugated
F(ab )2 goat Abs specific for mouse IgG. To characterize
the patched and capped structures with regard to Syk and
phospho-Syk colocalization, B cells were incubated with
RRX-conjugated Fab goat Abs specific for Ig , washed,
and the BCR cross-linked by the addition of goat Abs spe-
cific for mouse IgM. The cells were warmed to 37 C for
varying lengths of time, fixed, permeabilized, and stained
for Syk and phospho-Syk using rabbit Abs specific for Syk
or phospho-Syk (Y519/520) detected using AlexaFluor
488-conjugated Abs specific rabbit Ig. The cells were im-
aged by confocal laser scanning microscopy and the merged
images of the BCR and either phosphotyrosine, phospho-
Syk or Syk are shown (Fig. 8, a–c). The images were ana-
lyzed pixel by pixel as described above (Fig. 2 D) and the
data displayed in histograms. Similar structures were ob-
served in B cells from Cbl-b /  and Cbl-b /  mice and
shown are the images of Cbl-b /  B cells. Cross-linking
the BCR resulted immediately in BCR patches (Fig. 8, a–c,
top) that with time at 37 C formed large caps at one pole
of the cell (Cap I structures; Fig. 8, a–c, middle) that pro-
ceeded to form tight, condensed Cap II structures (Fig. 8,
a–c, bottom). The BCR in the patches and large Cap I
structures were nearly completely coincident with phos-
photyrosine-containing proteins as indicated in the merged
Figure 5. PLC- 2 phosphorylation and downstream Ca2  fluxes are
prolonged in activated Cbl-b /  B cells. (Top) B cells from Cbl-b /  and
Cbl-b /  mice were treated to cross-link the BCR as in Fig. 1, lysed, and
the lysates subjected to immunoprecipitation using PLC- 2–specific anti-
bodies. The immunoprecipitates were analyzed by immunoblot for phos-
photyrosine-containing proteins, stripped, and reprobed for PLC- 2. A
representative result of three independent experiments is shown. (Bot-
tom) B cells were incubated with Indo-1 for 45 min at 30 C and stained
with a PE-conjugated B220-specific mAb to allow gating on the B cells.
The cells were treated at 37 C with a rat mAb specific for IgM for 30 s
followed by F(ab )2 goat antibodies specific for rat IgG to cross-link the
BCR. The cells were monitored for 512s by flow cytometry for bound
(violet) and unbound (blue) Indo-1. The arrow indicates the time of addi-
tion of the secondary antibody.
Figure 6. The association of phosphorylated Syk with Vav1 is pro-
longed in Cbl-b /  B cells. Purified splenic B cells from Cbl-b /  and
Cbl-b /  mice were treated to cross-link the BCR as in Fig. 1. (A) The
cells were lysed and the lysates subjected to immunoprecipitation using
Vav1-specific Abs. The immunoprecipitates were analyzed by immuno-
blotting probing for phosphotyrosine using the mAb PY20. The blots
were stripped and probed for Vav1 or Syk. (B) Alternatively, the unfrac-
tionated lysates were analyzed by immunoblot probing for phospho-Akt
(S473) stripped and reprobed for Akt.T
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image showing colocalization of the red and green fluores-
cent dyes yielding yellow (Fig. 8 a, top, middle). In addi-
tion, the analyses of the distribution of the fluorescence in-
tensities of the green and red dyes showed that most pixels
lie along the diagonal of the histogram indicating colocal-
ization of IgM and phosphotyrosine-containing proteins
(Fig. 8 a, top, middle). Thus, both the patched and Cap I
structures appear signaling active. In contrast, the Cap II
BCR structures showed no staining for phosphotyrosine
indicating that these BCR structures are signaling inactive
(Fig. 8 a, bottom). The analyses of the red and green fluo-
rescence intensities showed little colocalization of red and
green dye with most pixels lying significantly above the di-
agonal (Fig. 8 a, bottom). The analysis of cells stained with
Syk-specific Abs showed near complete colocalization of
Syk with the BCR in patched and Cap I structures yielding
yellow in the image (Fig. 8 c, top, middle) and quantifica-
tion of the image showed a near complete colocalization of
the BCR and Syk. However, not all of the Syk associated
with the BCR in the patched and Cap I structures was ac-
tive phospho-Syk (Y519/520). The images of cells stained
to detect phospho-Syk (Y519/520) and the BCR show
distinct red areas indicating that the BCR was not com-
pletely colocalized with phospho-Syk (Y519/520). The
quantification of the image showed significant proportion
of the pixels lie above the diagonal indicating regions that
contain the BCR but not phospho-Syk (Y519/520). The
Cap II structures showed virtually no staining with either
the Syk-specific Abs (Fig. 8 c, bottom panel) or with the
phospho-Syk (Y519/520)-specific Abs (Fig. 8 b, bottom).
The condensed Cap II structures are often associated with
intracellular vesicles containing the BCR as shown in Fig.
8 c, bottom panel. Although the Cap II structures showed
no staining for Syk the vesicles containing internalized
BCR stained for Syk. The quantitation of the MFI of the
image showed two clear BCR areas one of which contains
Syk and one of which did not. This observation suggests
that the internalized BCR associated with Syk enters the
cell from active Syk-containing Cap I structures and not
from the signaling inactive Cap II structures. The BCR in
the Cap II structure may also be internalized but degraded
too rapidly to be imaged.
The number of patch, Cap I and Cap II structures
formed by B cells from Cbl-b /  and Cbl-b /  B cells after
BCR cross-linking were counted and compared (Fig. 8 d).
Similar numbers of B cells from Cbl-b /  and Cbl-b / 
mice formed patches with nearly all B cells showing a
patched morphology immediately after BCR cross-linking
which decreased with time at 37 C (Fig. 8 d, top). Signifi-
cantly, Cbl-b /  B cells formed BCR Cap I structures
more rapidly as compared with Cbl-b /  B cells such that
after 2 min at 37 C the BCR was in Cap I structures in
62% of Cbl-b /  B cells as compared with 32% of Cbl-b / 
B cells (Fig. 8 d, middle). In several experiments the time
course of polarization varied by 2–3 min but the acceler-
ated rate of polarization in Cbl-b /  versus Cbl-b /  was
observed in each experiment. The presence of BCR in
Cap I structures was sustained in B cells over the course of
the experiment in Cbl-b /  as compared with Cbl-b /  B
cells (50% versus 32%) in agreement with the observation
above (Fig. 2, D and E) that the BCR remained colocalized
with phospho-Syk for longer in Cbl-b /  as compared
with Cbl-b /  B cells. In addition, more Cbl-b /  B cells
progressed to form signaling inactive Cap II structures as
compared with Cbl-b /  B cells (Fig. 8 d, bottom) sug-
gesting that Cbl-b by negatively regulating the BCR sig-
naling promoted the condensing of the BCR into signaling
inactive Cap II structures.
The capping of the BCR has been shown to be depen-
dent on the association of the BCR with the actin cyto-
skeleton (35). The difference observed in the rate of BCR
caps was reflected in the rate of activation of CDC42 and
of F-actin polymerization (Fig. 9). CDC42 is a member of
the Rac family of GTPases that when activated binds to
WASP which promotes actin cytoskeleton association. The
level of activated CDC42 in B cells from Cbl-b /  and
Cbl-b /  mice at various times after BCR cross-linking
was determined by permeabilizing the cells and incubating
with the recombinant fusion protein WASP-GBD-GFP.
The GFP signal of the recombinant protein was amplified
by incubation with GFP-specific Abs detected using FITC-
conjugated secondary Abs. Cbl-b /  B cells showed an im-
mediate increase in active CDC42 which decreased by 2
min and remained at an elevated level for the course of the
Figure 7. ERK and JNK
phosphorylation are prolonged
and downstream CD69 expres-
sion increased in Cbl-b /  B
cells. (A) Purified splenic B cells
were treated to cross-link the
BCR as in Fig. 1. The cells
were lysed and equal amounts of
whole-cell lysates subjected to
immunoblotting using Abs spe-
cific for phospho-ERK (anti-
PERK) and phospho-JNK
(anti-PJNK). The blots were
stripped and reprobed for ERK1
and 2 and JNK1 and 2. (B) After
BCR cross-linking the cells were incubated for 20 h at which time the surface expression of CD69 was quantified by flow cytometry. The results are
the mean of duplicate cultures of one of three representative experiments.T
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experiment (Fig. 9 A). In contrast Cbl-b /  B cells showed
no immediate rapid increase in active CDC42 but rather
active CDC42 increased slowly in Cbl-b /  B cells reach-
ing levels comparable to those in Cbl-b /  B cells by 2
min. Actin polymerization was measured after BCR cross-
linking in permeabilized and fixed cells using Alexa 488-
conjugated phalloidin. Cbl-b /  B cells showed slightly ac-
celerated actin polymerization as compared with Cbl-b / 
B cells (Fig. 9 B). Consistent with these observations a
small but significantly larger proportion of the BCR was
found associated with the actin cytoskeleton in a high-den-
sity pellet from lysates of Cbl-b /  as compared with Cbl-
b /  B cells (unpublished data).
To directly assess the requirements for signaling and the
actin cytoskeleton in the formation of patch, Cap I and
Cap II structures, Cbl-b /  B cells were treated with the
following inhibitors: latrunculin (LN; reference 36) or Cy-
tochalasin D (CytD; reference 36), inhibitors of the actin
cytoskeleton; PP2, an inhibitor of Src family kinases (37);
and piceatannol (Pic), an inhibitor of Syk (38) that has also
been reported to inhibit additional protein tyrosine kinases
(39). As shown in Fig. 9 C, 2 min after BCR cross-linking
the BCR were patched on the majority of untreated cells.
Patching at 2 min after BCR cross-linking was not affected
by any inhibitor indicating that patching was not depen-
dent on Src or Syk signaling nor on an intact cytoskeleton.
This is despite the observation that phospho-Syk (Y519/
520) colocalized with the BCR in patches (Fig. 8 b). 10
min following BCR cross-linking the BCR were observed
in Cap I (60%) and Cap II structures (25%). Each inhibitor
significantly blocked the formation of Cap I structures and
the BCR in treated cells remained patched. Thus, the for-
mation of Cap I structures required both Src and Syk sig-
naling and an intact actin cytoskeleton. Significantly, in B
Figure 8. Signaling active BCR caps are prolonged in Cbl-b /  B cells. (a) Splenic B cells from Cbl-b /  mice were incubated with a rat mAb specific
for IgM at 4 C, washed and incubated with biotin-labeled goat antibodies specific for rat IgG and warmed to 37 C for increasing lengths of time. At the
end of each time point the cells were fixed and incubated with Texas Red–conjugated streptavidin to detect the BCR. The cells were permeabilized and
incubated with the phosphotyrosine-specific mAb PY20 detected using FITC-labeled F(ab )2 goat Abs specific for mouse IgG (b and c). Splenic B cells
from Cbl-b /  mice were incubated with RRX-conjugated Fab goat Abs specific for Ig  for 15 min at 25 C and the BCR was cross-linked by the
addition of goat Abs specific for mouse IgM. The cells were incubated at 37 C for increasing lengths of time, permeabilized, and incubated with either
rabbit phospho-Syk (Y519/520)-specific Abs (b) or with rabbit Syk-specific Abs (c) each detected using AlexaFluor 488-labeled goat Abs specific for
rabbit IgG. In each case, the cells were examined by confocal laser scanning microscopy and shown are the merged images of the optimal single planes at
a magnification of  63. Shown are typical images of patch, Cap I and Cap II structures taken for phosphotyrosine images at 5 min for patch and Cap I
structures and 30 min for Cap II structures and for Syk and phospho-Syk images at 0 min for patch, 2 min for Cap I, and 30 min for Cap II structures.
The images were analyzed by the LSM 5 software program to quantify the colocalization of red and green fluorescence and the data plotted in histo-
grams. (d) Purified splenic B cells from Cbl-b /  and Cbl-b /  mice were treated as in panel a to cross-link the BCR and cells were incubated at 37 C
for increasing lengths of time. At the end of each time point the cells were fixed with 3.7% paraformaldehyde, stained with Alexa 488-conjugated strepta-
vidin, and examined by fluorescence microscopy. The mean percentage ( SD) of B cells exhibiting the patch, Cap I and Cap II structures with time after
warming to 37 C is given. At least 500 cells at random were counted per time point.T
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cells treated with PP2 the number of cells with Cap I struc-
tures decreased and the number of cells with a Cap II mor-
phology increased indicating that when Src-dependent sig-
naling is blocked the BCR progresses to signaling inactive
Cap II structures.
Discussion
Here we provide evidence that in B cells Cbl-b func-
tions to negatively regulate BCR signaling by targeting Syk
for ubiquitination. In Cbl-b–deficient B cells Syk fails to be
ubiquitinated following BCR cross-linking in contrast to B
cells from wild-type mice in which case BCR cross-linking
leads to rapid ubiquitination of Syk. The results presented
suggest that Cbl-b ubiquitinates active phosphorylated Syk
and thus functions to dampen BCR signaling after signaling
is initiated and thus plays a role in the normal down modu-
lation of BCR signaling. Two additional negative regula-
tors of BCR signaling have been described recently,
namely SHIP and SHP-1. However, the targets of their
regulation appear distinct from that described here for Cbl-b.
SHIP, a 5  inositol phosphatase, was first described to
block BCR signaling when recruited to the low affinity Fc
receptor, Fc RIIb, after the coligation of the BCR and
Fc RIIb by the binding of immune complexes (40). SHIP
dephosphorylates PIP(3,4,5)P3, the phospholipid product
of PI-3K activity, to PI(3,4)P2. Recently, SHIP-deficient
B cells were shown to have elevated levels of PI(3,4,5)P3
(11) increased recruitment of Btk to the plasma membrane
(12) and enhanced Ca2  signaling (13). However, ERK ac-
tivation appeared unaffected in SHIP-deficient cells (13). In
contrast, Cbl-b does not appear to effect PI3K activity or
PI3K-downstream effectors but does influence ERK activ-
ity. SHP-1, a tyrosine phosphatase, was recently shown to
down-regulate the activation of Lyn and Lyn-induced ty-
rosine phosphorylation of the CD19 receptor in B cells re-
sulting in reduced B cell activation (14). As shown here,
Cbl-b does not appear to affect Lyn activity. Thus, these
three negative regulators of BCR signaling appear to target
different elements of the BCR signaling pathways leading
to down modulation of B cell responses. It will be of inter-
est to understand the mechanisms which trigger the activity
of these regulators and how their activities are coordinated.
Lymphocytes express both c-Cbl and Cbl-b. In T cells
Cbl-b and c-Cbl appear to function at different stages of
development and to target different substrates for ubiquit-
ination. c-Cbl has been reported to target Syk for ubiquit-
ination in human Ramos B cells upon BCR cross-linking
and in this way to function as a negative regulator of B
cell activation (17). Thus, Cbl-b and c-Cbl may have
somewhat redundant functions in regulating mature B cell
activation through the ubiquitination of Syk. However,
recent studies suggest that Cbl-b and c-Cbl may function
differently and regulate different targets in developing ver-
sus mature B cells. In immature DT40 chicken B cells ev-
idence was provided that c-Cbl negatively regulates BCR
signaling through its affect on the essential adaptor protein
BLNK resulting in a block in the recruitment of PLC- 2
to BLNK and PLC- 2 phosphorylation (41). In contrast,
Cbl-b was shown to positively regulate Btk-mediated ac-
tivation of PLC- 2 in immature DT40 B cells (24). Evi-
dence was also provided that Cbl-b functioned similarly in
Figure 9. CDC42 activation and actin polymer-
ization are enhanced in Cbl-b–deficient B cells. (A)
Purified splenic B cells from Cbl-b /  and Cbl-b / 
mice were treated to cross-link the BCR as in Fig.
2, A–C, incubated at 37 C for the times indicated,
fixed, permeabilized, and incubated with the
WASP-GBD-GFP fusion protein followed by in-
cubation with FITC-conjugated-rabbit antibodies
specific for GFP and then FITC-conjugated goat
antibodies specific for rabbit Ig. The cells were ana-
lyzed by flow cytometry and the results presented as
the percent increase in mean fluorescence of acti-
vated B cells relative to the mean fluorescence of
resting B cells. (B) B cells were treated as in panel A
and permeabilized cells were stained with Alexa
488–conjugated phalloidin and analyzed by flow
cytometry. Shown is the percent increase of the
mean fluorescence of stimulated B cells relative to
the mean fluorescence intensity of resting cells at
each time point. (C) Splenic B cells from Cbl-b / 
mice were pretreated with the following inhibitors:
piceatannol (100  M for 1 h at 37 C) a Syk inhibi-
tor(38); PP2 (100  M for 1 h at 37 C) a Src-family
kinase inhibitor (reference 37); and Cytochalasin D
(10  M for 1 h at 0 C; reference 36) or Latrunculin
(10  M for 30 min at 37 C; reference 36) inhibi-
tors of the actin cytoskeleton. The pretreated cells
were incubated with a rat mAb specific for IgM,
washed and incubated for 2 or 10 min at 37 C with
biotin-labeled F(ab )2 goat antibodies specific for rat IgG, fixed and stained with Alexa 488–labeled streptavidin to visualize the BCR. The cells were ex-
amined by fluorescence microscopy and the number of cells showing a patch, Cap I or Cap II morphology were scored.T
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the immature mouse WEHI B cells. In control experi-
ments, PLC- 2 was shown to be phosphorylated to simi-
lar levels in mature Cbl-b /  and Cbl-b /  B cells 1 min
after BCR cross-linking consistent with the results pre-
sented here. Taken together these findings suggest that
Cbl-b and c-Cbl may provide overlapping functions in
the regulation of Syk in mature B cells but have distinct
targets in immature B cells resulting in both positive and
negative regulation.
The molecular mechanism by which Cbl-b facilitates the
ubiquitination of Syk is not known. Ubiquitination is initi-
ated by the linkage of ubiquitin (Ub) to an Ub-activating
enzyme, E1. Ub is then transferred by E1 to an Ub con-
jugating enzyme, E2, that subsequently conjugates the
COOH terminus of Ub to a lysine on the target protein
through a isopeptide bond. The specificity of ubiquitina-
tion is largely determined by Ub protein ligases, E3s, which
interact with both E2s, through RING finger domains, and
the E2 substrates and thus facilitate the conjugation of Ub
to the target protein (42). Members of the Cbl family are
E3 ligases that bind to the kinases targeted for ubiquitina-
tion through their TKB domains (16). The ubiquitination
of Syk by c-Cbl minimally requires the TKB and RING
finger domain of c-Cbl. The TKB domain of c-Cbl binds
to tyrosine 317(Y317) in the linker region between the
SH2 and the catalytic domains of mouse Syk when it is
phosphorylated following BCR cross-linking. A mutant
form of Syk that lacks the Y317 showed an enhanced abil-
ity to interact with Ig  suggesting that the association of
c-Cbl with Syk blocks its ability to interact with Ig  and to
couple the BCR to downstream signaling pathways (43).
Based on these observations a model can be proposed for
the regulation of BCR signaling by Cbl-b in which BCR
cross-linking results in the phosphorylation of Ig , the re-
cruitment of Syk to Ig  through the SH2 domains of Syk
and phosphorylation of Syk at multiple tyrosines including
Y317. Cbl-b would bind to Syk Y317 through its TKB
domain resulting in both the modulation of Syk/Ig associa-
tion and the ubiquitination of Syk by an E2 conjugating
enzyme bound to the RING finger domain of Cbl-b. The
ubiquitinated Syk would be subsequently degraded. Con-
sistent with this model we observe that in Cbl-b–deficient
B cells Syk is not ubiquitinated and the phosphorylation of
Ig  and association of Ig  with phosphorylated Syk is pro-
longed. These events correlated with the prolonged associ-
ation of phosphorylated Syk with Vav, the prolonged
phosphorylation of BLNK, PLC- 2, ERK, and JNK, in-
creased and prolonged Ca2  fluxes, and increases in the ex-
pression of the activation marker CD69. Also consistent
with a model in which Cbl-b targets Syk for degradation
was the observation that the activation of Lyn was not sig-
nificantly affected in Cbl-b-deficient B cells. Thus, by tar-
geting Syk for degradation and modulating its association
with Ig , Cbl-b regulates several downstream signaling
pathways of Syk. It is of interest that the PI3K pathway was
apparently not influenced in Cbl-b–deficient B cells. It re-
mains to be determined if this is due to a functional redun-
dancy of Cbl-b and c-Cbl.
Cbl-b also appeared to influence the formation of stable,
signaling active BCR caps after BCR cross-linking. In T
cells the polarization of the TCR after ligation and the for-
mation of the supramolecular activation complex and the
immunological synapse appear to be crucial prerequisites
for T cell activation (44). Evidence has been provided that
Cbl-b influences this process by negatively regulating the
coupling of the TCR to Vav-1 and downstream CDC42
and WASP, leading to actin cytoskeleton-dependent TCR
clustering (45). In B cells, the BCR has been shown to po-
larize after cross-linking into structures that concentrate
Syk, Vav, Btk, and Rac and thus appear analogous to the T
cell immunological synapses (46). Here we show that in B
cells from Cbl-b–deficient mice as compared with wild-
type B cells the BCR remains in a signaling active Cap I
structure for longer periods of time and less BCR is found
condensed in signaling inactive Cap II structures. Al-
though the functional significance of the Cap II structures
is not known, it is possible that they represent preendocy-
totic structures involved in the removal of signaling inac-
tive BCR from the surface. However, although Cap II
structures often appear near intracellular vesicles that con-
tain internalized BCR we show here that the intracellular
BCR is associated with Syk while the Cap II BCR is not.
Earlier studies showed that internalization of the BCR is
dependent on BCR signaling although the exact nature of
the signals required is not known. The studies presented
here suggest that BCRs may be internalized from active
Cap I structures as a part of normal down modulation of
the response. As receptors are internalized and signaling
dampened the BCRs remaining on the surface may con-
dense into Cap II structures which are then internalized
and degraded.
In summary, the studies presented here provide evidence
that Cbl-b negatively regulates Syk through ubiquitination.
Thus, Cbl-b has the potential to block BCR signaling at an
early step effectively uncoupling the BCR from many
downstream signaling pathways. Consequently, it will be of
significant interest to determine the factors that induce and
regulate Cbl-b activity.
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